A double-blind multicenter, randomized, placebo-controlled single dose study to evaluate the safety and efficacy of Trexima in the acute treatment of migraine headaches.

Trial Profile

A double-blind multicenter, randomized, placebo-controlled single dose study to evaluate the safety and efficacy of Trexima in the acute treatment of migraine headaches.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Naproxen sodium; Naproxen sodium/sumatriptan; Sumatriptan
  • Indications Migraine
  • Focus Registrational; Therapeutic Use
  • Sponsors POZEN
  • Most Recent Events

    • 13 Sep 2009 Results from a pooled analysis (CTP profiles 700021536 and 700021530) were reported at the 14th International Headache Congress & the 51st Annual Scientific Meeting of the American Headache Society (Joint meeting).
    • 10 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top